| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |